Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Emilio Iannitto, Monica Bellei, Sandy Amorim, Andrés J.M. Ferreri, Luigi Marcheselli, Marina Cesaretti, Corinne Haioun, Salvatrice Mancuso, Krimo Bouabdallah, Remy Gressin, Claudio Tripodo, Alexandra Traverse-Glehen, Lucile Baseggio, Simonetta Zupo, Caterina Stelitano, Barbara Castagnari, Caterina Patti, Isabel Alvarez, Anna Marina Liberati, Michele MerliGuido Gini, Maria Giuseppina Cabras, Jean Dupuis, Benoit Tessoulin, Aurore Perrot, Francesca Re, Francesca Palombi, Alessandro Gulino, Emanuele Zucca, Massimo Federico, Catherine Thieblemont

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study'. Together they form a unique fingerprint.

Medicine & Life Sciences